CA 19-9 Tumour Marker Blood Test (Cancer Antigen 19-9)

The CA 19-9 blood test measures a tumour marker associated with certain cancers. It is used to support monitoring and treatment assessment but is not intended to diagnose or screen for cancer.

  • Doctor reviewed
Sample
Blood
Collection
Venous draw at clinic or nurse home visit
Results in
1 day
Biomarkers
1
Doctor reviewed
Yes
Tests for
  • CA 19-9

Test specifications

Sample type
blood
Collection method
venous draw at clinic or nurse home visit
Turnaround time
1 day
Biomarkers tested
1
At-home test
No
Doctor reviewed
Yes
Gender focus
Both

What's tested

1 biomarker as listed by Blue Horizon Medicals.

  • CA 19-9

About this test

The CA 19-9 blood test measures the level of Cancer Antigen 19-9 (CA 19-9), a tumour marker that may be elevated in certain cancers and some non-cancerous conditions.

The CA 19-9 tumour marker blood test is not a diagnostic test or a general screening test for cancer. It is primarily used alongside other clinical investigations to monitor patients with a known condition, assess response to treatment, or check for changes over time.

A raised CA 19-9 result does not necessarily mean that cancer is present. Levels may also be increased by a range of benign conditions, including inflammation, gallstones, bile duct obstruction, pancreatitis and liver disease.

Results should always be interpreted by a doctor alongside your symptoms, medical history, imaging scans and any other relevant laboratory tests.

Description provided by Blue Horizon Medicals.

View all →

TruCheck™ Early Cancer Screening Blood Test

Check for over 70 types of cancer with the TruCheck™ Early Multi-Cancer Screening blood test. This ground-breaking, at-home blood test for cancer checks for the early detection of cancer in people over 35 years of age, including breast, ovarian, melanoma, liver, lung and prostate cancer.